Alternatives to Lembas Bio

Gut health brand offering science-backed functional foods to support metabolic health and appetite control.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Developing novel therapies for rare genetic disorders and unmet medical needs.

Developing antisense oligonucleotide (ASO) therapies for rare genetic disorders.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Compressing biology to develop the next generation of therapies.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered epiproteomic analysis platform for mass spectrometry data.